Rebecca E Mercer

8PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Social epidemiologyEpidemiological modellingCancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 06, 2026
Comparative effectiveness of chimeric antigen receptor (CAR) T-cell therapy versus historical controls in patients with relapse/refractory aggressive B-cell lymphoma: An indirect treatment comparison in the real-world setting.

|Jun 25, 2026
A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma.

|Nov 26, 2025
Examining the Association Between Equity-Related Factors and EQ-5D-3L Health Utilities of Patients with Cancer.

Teresa C O Tsui, Rebecca E Mercer, Eleanor M Pullenayegum

|Jun 25, 2025
Patient Experiences Regarding Feasibility of Implementing Real-World EQ-5D Collection at an Oncology Centre in Ontario, Canada.

Teresa C O Tsui, Rebecca E Mercer, Elena J Zhou

|Apr 23, 2025
Real-world comparative effectiveness and safety of Pertuzumab in patients with HER2+ metastatic breast cancer: A pan-Canadian population-based cohort study.

Caroline E Muñoz, Wei Fang Dai, Winson Y Cheung

|Apr 26, 2024
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.

Pam Takhar, Marc Geirnaert, Scott Gavura

Pageof 2

Frequent Collaborators

3 joint publications

Scott Gavura

2 joint publications

Avram Denburg

2 joint publications

Stuart Peacock

2 joint publications

Pierre J A Villeneuve